Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ionetix Alpha is a subsidiary vehicle created by Ionetix to run its therapeutic alpha-radionuclide business. It operates commercial‑scale, GMP production and radiolabeling of actinium-225 and astatine-211 for use by biopharma partners in targeted alpha therapy programs; it does not run its own drug trials but supplies isotopes and CDMO services into multiple external clinical programs.[1][2][5][8][9]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ionetix Alpha.